Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

A clinical trial to learn about the effects of YTB323 in people with difficult to treat severe diffuse cutaneous systemic sclerosis (dcSSc) Recruiting

2023-510380-34-00 Diffuse cutaneous systemic sclerosis (dcSSc) 4 2024-12-10
Abatacept for therapy of IgG4-related disease Recruiting

2024-512863-30-00 IgG4-related disease 4 2024-12-09
Positron emission tomography with macrophage targeting to select individuals at risk for rheumatoid arthritis. Recruiting

2024-513538-40-02 ACPA positive arthralgia 4 2024-12-09
This is a study to evaluate safety and efficacy of Upadacitinib comparing to Dupilumab in children from 2 to less than 12 years of age with … Recruiting

2023-504713-76-00 Dermatitis atopic 5 2024-12-03
Design and evaluation of an individualized biodrug tapering strategy based on biodrug dosage: the MONITORA study_STEP1 Recruiting

2024-514313-35-00 Arthritis rheumatoid 6 2024-12-03
Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study Recruiting

2023-508558-25-01 Type 1 Diabetes 9 2024-12-02
A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 2 trial to evaluate the efficacy and safety of BP1.7881 in… Recruiting

2023-508949-40-00 Eosinophilic esophagitis 4 2024-11-29
COMparison of B-cell dePletion by rituximAb and anti-CD 19 CAR-T therapy in patients with rhEumatoid arthritis- The COMPARE TRIAL Recruiting

2024-514955-13-00 Rheumatoid Arthritis 9 2024-11-29
[18F]PEG-folate PET-CT imaging for monitoring of therapy response in Rheumatoid Arthritis patients Recruiting

2024-513537-21-02 Rheumatoid Arthritis 4 2024-11-27
Anti-CD19 CAR T-Cell TherApy in Refractory Systemic Autoimmune DISeases - CATARSIS Recruiting

2024-511293-74-01 Refractory Systemic Autoimmune Diseases 9 2024-11-26
R-HLH Recruiting

2024-516105-23-01 haemophagocytic lymphohistiocytosis (HLH) in children 4 2024-11-10
A Phase II randomized trial of RSV vaccination in allogeneic hematopoietic stem cell transplant recipients (RSV-Allo study) Recruiting

2024-513290-53-00 allogeneic - Hematopoietic Stem Cell Transplantation 10 2024-11-07
Induction therapy for lupus nephritis with no added oral corticosteroids : An open label randomised multicentre controlled trial comparing … Recruiting

2024-516242-19-00 lupus nephritis 5 2024-11-05
Long-term safety and tolerability of cenerimod in adults with systemic lupus erythematosus (OPUS OLE) Recruiting

2024-514354-67-00 Systemic lupus erythematosus 5 2024-11-01
MANUS trial Recruiting

2024-515387-31-00 Systemic Sclerosis 4 2024-11-01
Efficacy and Safety of Obinutuzumab versus Rituximab in childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome : à double-bli… Recruiting

2024-514240-93-00 Idiopathic nephrotic syndrome (INS) 10 2024-10-31
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects with WAS. Recruiting

2024-517792-20-00 Wiskott-Aldrich Syndrome 5 2024-10-29
A Long-term Extension Study of Guselkumab in Pediatric Participants Recruiting

2023-509560-16-00 Juvenile psoriatic arthritis (jPsA) 5 2024-10-29
QUIDOSE. Randomized controlled trial testing the efficacy of hydroxychloroquine combined with low dose corticosteroid therapy in pulmonary s… Recruiting

2024-516101-23-00 Sarcoidosis 5 2024-10-28
MOVE-JIA trial Recruiting

2024-513017-12-00 Juvenile Idiopathic Arthritis 6 2024-10-24
Study of the efficacy and safety of etanercept treatment in patients with SAPHO syndrome Recruiting

2024-516919-25-00 SAPHO syndrome (synovitis, acne, pustulosis, hyperostos 10 2024-10-22
A multi-center randomized phase II study comparing corticosteroids alone versus corticosteroids and extracorporeal photopheresis as first-li… Recruiting

2023-508614-41-00 The study will be proposed to all adult patients receiv 4 2024-10-15
CLADRIBINE DOSE ESCALATION IN CONDITIONING REGIMEN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (Allo-HSCT) FOR REFRACTORY AC… Recruiting

2024-515737-14-00 Acute leukemia and myelodysplastic syndromes 3 2024-10-07
A study to test the efficacy and safety of riliprubart against the usual treatment of intravenous immunoglobulin (IVIg) in people with chron… Recruiting

2023-508338-33-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2024-10-01